Myocardial infarction post COVID-19 vaccine - coincidence, Kounis syndrome or other explanation - time will tell
- PMID: 34394944
- PMCID: PMC8361528
- DOI: 10.1177/20542704211025259
Myocardial infarction post COVID-19 vaccine - coincidence, Kounis syndrome or other explanation - time will tell
Abstract
A case of ST elevation myocardial infarction reported post Coronavirus disease 2019 (COVID-19) vaccine. Probably premature to draw a link between COVID-19 vaccine and myocardial infarction.
Keywords: COVID-19 vaccine; excipients; myocardial infarction.
© The Author(s) 2021.
Figures
References
-
- A Phase 2/3 study to determine the efficacy, safety and immunogenicity of the candidate Coronavirus Disease (COVID-19) vaccine ChAdOx1 nCoV-19. Responsible Party: University of Oxford Clinical. Trials.gov Identifier: First Posted: May 26, 2020. Last Update Posted: April 21, 2021. Estimated Primary Completion Date September 2021.https://clinicaltrials.gov.NCT04400838.
-
- Voysey M, Clemens SAC, Madhi SA, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomized controlled trials in Brazil, South Africa, and the UK. Lancet 2021; 397(10269): 99--111. doi: 10.1016/S0140-6736(20)32661-1. Epub 2020 Dec 8. Erratum in: Lancet. 2021 Jan 9;397(10269):98. PMID: 33306989; PMCID: PMC7723445. - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources